Cargando…
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316222/ https://www.ncbi.nlm.nih.gov/pubmed/32584817 http://dx.doi.org/10.1371/journal.pntd.0008259 |
| _version_ | 1783550392247779328 |
|---|---|
| author | Malvy, Denis Taburet, Anne-Marie de Lamballerie, Xavier Mentre, France Extramiana, Fabrice |
| author_facet | Malvy, Denis Taburet, Anne-Marie de Lamballerie, Xavier Mentre, France Extramiana, Fabrice |
| author_sort | Malvy, Denis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7316222 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73162222020-06-29 The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers Malvy, Denis Taburet, Anne-Marie de Lamballerie, Xavier Mentre, France Extramiana, Fabrice PLoS Negl Trop Dis Viewpoints Public Library of Science 2020-06-25 /pmc/articles/PMC7316222/ /pubmed/32584817 http://dx.doi.org/10.1371/journal.pntd.0008259 Text en © 2020 Malvy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Viewpoints Malvy, Denis Taburet, Anne-Marie de Lamballerie, Xavier Mentre, France Extramiana, Fabrice The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| title | The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| title_full | The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| title_fullStr | The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| title_full_unstemmed | The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| title_short | The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| title_sort | safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers |
| topic | Viewpoints |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316222/ https://www.ncbi.nlm.nih.gov/pubmed/32584817 http://dx.doi.org/10.1371/journal.pntd.0008259 |
| work_keys_str_mv | AT malvydenis thesafetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT taburetannemarie thesafetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT delamballeriexavier thesafetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT mentrefrance thesafetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT extramianafabrice thesafetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT malvydenis safetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT taburetannemarie safetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT delamballeriexavier safetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT mentrefrance safetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers AT extramianafabrice safetyprofileoffavipiravirshouldnotbethefirstargumenttosuspenditsevaluationinviralhemorrhagicfevers |